« Return to News | CROs/Service Providers

DSM inks South American biologics contract manufacturing agreement

Monday, July 23, 2012 12:46 PM

DSM Pharmaceutical Products, a custom manufacturing and technology business of Royal DSM, has signed a biologics contract manufacturing agreement with its first Brazilian client, Recepta Biopharma, a Sao Paulo-based biotechnology company focused on monoclonal antibodies to treat cancer.

"This manufacturing agreement with DSM moves us one step closer to serving patient needs for this important medical treatment,” said Jose Fernando Perez, CEO of Recepta Biopharma. “We are delighted to strengthen our global network of innovation to bring our new monoclonal antibodies to the market."

The contract covers the process development and cGMP manufacture by DSM of one of Recepta's lead antibodies at its facilities based in Groningen, The Netherlands. DSM started production to supply drug substance materials to be used in the initial clinical trials of this antibody beginning in May of 2012.

"We have developed a productive partnership throughout the course of this project and we are confident that the research that Recepta has carried out to date will be successfully implemented by the industry leading expertise of DSM's team,” said Karen King, president of DSM Biologics.

The project also represents DSM Biologics’ first agreement in the high growth South American market place.

"Working with Recepta in Brazil marks further advancement of DSM's stated strategy to grow its presence in high growth economies such as Brazil and South America,” said Alexander Wessels, CEO of DSM Pharmaceutical Products.

Financial terms were not disclosed.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.